OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: The Chinese University of Hong Kong

2 Projects | 2 Researchers | $691,204 Invested

2020

The Chinese University of Hong Kong

Guoliang Xing, PhD

Machine Learning Technologies for Advancing Digital Biomarkers for Alzheimer's Disease

  • Funding Amount: $641,204
  • Organization Type: Academic/Nonprofit
  • Program: Biomarkers
  • Status: Active

2007

The Chinese University of Hong Kong

Larry Baum, PhD

Testing 17-AAG for Treating Fronto-Temporal Dementia

  • Funding Amount: $50,000
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Status: Closed